Gao H, Niu G, Yang M, Quan Q, Ma Y, Murage EN, Ahn JM, Kiesewetter DO, Chen X
The decision on semaglutide is expected soon as well with Novo telling Hunterbrook in a statement that it is happy to share that the status of all our GLP-1 medicine presentations for Ozempic and WeGovy are now reflected on the FDA shortage website as, Available. All doses of these products are being shipped regularly to wholesalers, the company added, reiterating that it is deeply concerned about companies promoting and selling compounded, non-FDA approved knock-off versions of semaglutide. A Hunterbrook investigation earlier this year revealed concerning practices at Hims
Iron deficiency is perhaps the most significant
Yes, GLP-1 receptor agonists can cause bloating as a side effect due to delayed gastric emptying, which slows digestion and may lead to abdominal distension